Juan Graham
Juan Graham's purchase track record
Juan Graham has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/28/2025 | CATX | $75K | +70.9% | +54.5% | +19.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Kyntra Bio Names Andrew Singer to Board. Kyntra Bio has added Andrew E. Singer, MBA, to its board of directors. The move expands the company’s leadership team and could bring new expertise to its strategic planning. The appointment follows the company’s ongoing efforts to strengthen governance and support its growth initiatives. Investors may view the change as a sign of continued focus on development and operational improvement.
Transaction History
| CATX | ▲ Buy | Open Market | 33,333 | $75K | 3/28/2025 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,066 | $365 | 12/7/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,446 | $495 | 12/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,065 | $415 | 9/7/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 16,050 | $6K | 9/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,182 | $1K | 6/7/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 17,797 | $21K | 6/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,181 | $2K | 3/7/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 20,327 | $38K | 3/6/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 422 | $789 | 3/6/2024 | View on chart |
| KYNB | ▲ Buy | Grant | 781 | $0 | 3/6/2024 | View on chart |
| KYNB | ▲ Buy | Grant | 52,000 | $0 | 2/21/2024 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,085 | $668 | 12/7/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 15,573 | $9K | 12/6/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 1,096 | $1K | 9/7/2023 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 711 | $685 | 9/6/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 120,000 | $0 | 8/30/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 1,050 | $18K | 6/7/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 735 | $13K | 6/7/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 1,112 | $22K | 3/10/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 1,456 | $29K | 3/10/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 2,344 | $47K | 3/10/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 4,668 | $0 | 3/8/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 2,749 | $58K | 3/8/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 2,899 | $0 | 3/8/2023 | View on chart |
| KYNB | ▲ Buy | Grant | 25,000 | $0 | 2/21/2023 | View on chart |
| KYNB | ▼ Sell | Open Market | 1,407 | $20K | 12/12/2022 | View on chart |
| KYNB | ▼ Sell | Open Market | 781 | $12K | 12/9/2022 | View on chart |
| KYNB | ▼ Sell | Open Market | 5,263 | $78K | 12/8/2022 | View on chart |
| KYNB | ▼ Sell | Open Market | 478 | $7K | 12/8/2022 | View on chart |
| KYNB | ▼ Sell | Tax Withholding | 3,009 | $38K | 9/7/2022 | View on chart |
| KYNB | ▲ Buy | Grant | 22,500 | $0 | 2/14/2022 | View on chart |
| KYNB | ▲ Buy | Grant | 35,000 | $0 | 9/7/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
CATX included in pre-market movers list
Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.
CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.